13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q4 2023 · Filed October 3, 2023 · Accession 0000950123-23-008652
Total Value
$64.6M
Positions
8
Other Managers
0
Confidential Omitted
No
Holdings (8)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Centessa Pharmaceuticals plc | CNTA | 3,931,818 | $25.4M | 39.38% |
| 2 | Dyne Therapeutics, Inc. | DYN | 2,220,034 | $19.9M | 30.79% |
| 3 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $5.7M | 8.82% |
| 4 | Kronos Bio, Inc. | 50107A104 | 2,765,314 | $3.6M | 5.56% |
| 5 | LianBio | LIANY | 2,282,084 | $3.4M | 5.26% |
| 6 | Kinnate Biopharma, Inc. | 49705R105 | 2,207,772 | $3.1M | 4.78% |
| 7 | Praxis Precision Medicines, Inc. | PRAX | 1,469,665 | $2.5M | 3.89% |
| 8 | Ikena Oncology, Inc. | 45175G108 | 225,192 | $975,081 | 1.51% |